Table 2.
Association of GR expression in TNBC cells with immune cell percentage of total cell number in averaged ROIs
| Characteristic | All Tumors (n = 39) |
Low GR (n = 7) |
Moderate GR (n = 18) |
High GR (n = 14) |
p-value* |
|---|---|---|---|---|---|
| CD8+(%) | |||||
| Mean | 1.56 | 0.27 | 1.34 | 2.48 | 0.068 |
| SD | 3.40 | 0.32 | 2.08 | 5.11 | |
| Range | 0–19.86 | 0.01–0.94 | 0–7.80 | 0–19.86 | |
| FOXP3+(%) | |||||
| Mean | 0.83 | 0.40 | 0.77 | 1.13 | 0.046 |
| SD | 0.701 | 0.36 | 0.57 | 0.87 | |
| Range | 0–2.98 | 0.04–0.91 | 0.03–2.03 | 0–2.98 | |
| BATF3+(%) | |||||
| Mean | 0.065 | 0.028 | 0.058 | 0.092 | 0.021 |
| SD | 0.074 | 0.042 | 0.071 | 0.084 | |
| Range | 0–0.283 | 0–0.102 | 0–0.269 | 0–0.283 | |
| CD8 +/FOXP3+ ratio | |||||
| Mean | 1.27a | 0.81 | 1.24 | 1.55b | 0.24 |
| SD | 1.30 | 0.65 | 1.24 | 1.61 | |
| Range | 0–6.31 | 0.10–1.88 | 0–3.87 | 0.1–6.31 |
*Nonparametric trend test an=38, bn=13
Significant values (p-value < 0.05) are in bold text